Foamix Pharmaceuticals Ltd (FOMX) Return on Equity ROE from the fourth quarter 2019 to fourth quarter 2018 and annually, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket
 


Foamix Pharmaceuticals Ltd   (FOMX)

Foamix Pharmaceuticals Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Foamix Pharmaceuticals Ltd in the fourth quarter 2019?
Foamix Pharmaceuticals Ltd achieved a return on average equity (ROE) of 181.74 % in its fourth quarter 2019 a new company high.

ROE has advanced compared to 100.58% in the third quarter 2019, due to net income growth.

Within the Legal Cannabis industry Foamix Pharmaceuticals Ltd achieved the highest return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 63, from total ROE ranking in the third quarter 2019 at 80.

What is ROE?




Return On Equity (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Equity Change -80.93 % -49.05 % 37.55 % 75.89 % -
Y / Y Net Income Change 168.65 % 49.62 % 1.96 % -41.47 % -
Net Income (TTM) in Millions 95 71 64 63 74
Return On Equity (TTM) 181.74 % 100.58 % 75.99 % 79.45 % 103.91 %
FOMX's Total Ranking # 63 # 80 # 104 # 79 # 65
Equity (TTM) in Millions 18 54 60 78 92
Seq. Equity Change -67.17 % -11.35 % -22.58 % -15.39 % -12.26 %
Seq. Net Income Change 63.29 % 21.94 % 24.92 % 8 % -9.06 %

Return On Equity Company Ranking
Within: No.
Industry # 1
Sector # 6
Overall # 63

Return On Equity Statistics
High Average Low
181.74 %
66.3 %
-33.87 %
(Dec 31 2019)   (Dec 31 2017)





FOMX Annual Return On Equity (Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
(Dec 31 2015)
2015
Total Equity in Millions 18 92 69 130 101
Y / Y Equity Change -80.93 % 34.37 % -47.22 % 28.95 % 106.72 %
Net Income in Millions 95 74 66 29 17
Y / Y Net Income Change 28.34 % 12.86 % 124.01 % 77.61 % 43.83 %
Return On Equity 541.55 % 80.45 % 95.79 % 22.57 % 16.39 %





Annual Roe Comment
In 2019 ROE improved to 541.55 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Legal Cannabis Industry Roe Trends and Statistics
Consumer Non Cyclical Sector Return On Equity Statistics
FOMX's' Return on Equity at Yahoo Finance
FOMX's Roe Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for FOMX's Competitors
Subscribers only: Roe for Foamix Pharmaceuticals Ltd 's Suppliers
Subscribers only: Return On Equity for FOMX's Customers




Companies with similar Return On Equity at Dec 31 2019, within Consumer Non Cyclical Sector ROE
Sow Good Inc  275.71 %
Cronos Group Inc   209.84 %
The Davey Tree Expert Company  185.81 %
Foamix Pharmaceuticals Ltd   181.74 %
Utz Brands Inc   159.49 %
The Clorox Company  133.28 %
The Campbells Company  123.14 %
Whole Earth Brands Inc   104.79 %
Fitlife Brands Inc   85.15 %
Cvr Partners Lp  83.46 %
Ambev S a   78.31 %
Hershey Co  69.35 %
Medifast Inc   67.15 %
Scotts Miracle gro Co  65.23 %
Eos Inc   58.23 %
U S Premium Beef Llc  55.29 %
Pepsico Inc   51.22 %
Brown forman Corporation  49.75 %
Tattooed Chef Inc   47.00 %
Coca Cola Co  43.89 %
Unilever Plc  43.40 %
Unilever N V  43.40 %
United guardian Inc   42.09 %
Est e Lauder Companies Inc  41.65 %


Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.